Journal article icon

Journal article

TNF as a therapeutic target

Abstract:
Tumor necrosis factor α (TNF-α) is a well-recognized proinflammatory cytokine, and as such provides an ideal target for anti-inflammatory therapies. Recent developments have shown very exciting results, and in this article, Jan Bondeson, Marc Feldman, and Ravinder N. Maini review the outcome of clinical trials of anti-TNF-α therapies in a range of chronic inflammatory diseases.
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
Journal:
IMMUNOLOGIST
Volume:
8
Issue:
6
Pages:
136-140
Publication date:
2000-01-01
ISSN:
1192-5612
URN:
uuid:153f1289-18a0-4e0f-a471-bc6650fe19b3
Source identifiers:
226139
Local pid:
pubs:226139
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP